Anthony Laurie Abner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Ductal, Breast | 3 | 2001 | 1096 | 0.230 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 11345 | 0.210 |
Why?
|
| Breast Neoplasms, Male | 1 | 2001 | 221 | 0.170 |
Why?
|
| Orbital Neoplasms | 1 | 2001 | 221 | 0.160 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 1442 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15760 | 0.140 |
Why?
|
| Exanthema | 1 | 2001 | 504 | 0.140 |
Why?
|
| Breast Neoplasms | 14 | 2005 | 21029 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2000 | 586 | 0.130 |
Why?
|
| Carcinoma, Lobular | 1 | 2000 | 489 | 0.130 |
Why?
|
| Androgens | 1 | 2023 | 1291 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2005 | 9278 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 1 | 2001 | 935 | 0.120 |
Why?
|
| Carcinoma in Situ | 1 | 2000 | 796 | 0.120 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 416 | 0.110 |
Why?
|
| Esthetics | 2 | 1992 | 326 | 0.100 |
Why?
|
| Mastectomy, Segmental | 7 | 2005 | 972 | 0.100 |
Why?
|
| Radiotherapy, Conformal | 2 | 2005 | 549 | 0.090 |
Why?
|
| Combined Modality Therapy | 12 | 2005 | 8552 | 0.090 |
Why?
|
| Salvage Therapy | 2 | 2005 | 1268 | 0.080 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 282 | 0.060 |
Why?
|
| Mastectomy | 1 | 1993 | 1832 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 597 | 0.060 |
Why?
|
| Lung Neoplasms | 3 | 1997 | 13262 | 0.050 |
Why?
|
| Particle Accelerators | 1 | 2003 | 174 | 0.050 |
Why?
|
| Radiation Injuries | 2 | 2005 | 1183 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 1997 | 5251 | 0.040 |
Why?
|
| Radiotherapy Dosage | 5 | 2001 | 2897 | 0.040 |
Why?
|
| Exophthalmos | 1 | 2001 | 97 | 0.040 |
Why?
|
| Axilla | 1 | 1998 | 626 | 0.030 |
Why?
|
| Stents | 1 | 1998 | 3303 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 2529 | 0.030 |
Why?
|
| Humans | 24 | 2023 | 760613 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 1993 | 11713 | 0.030 |
Why?
|
| Mastectomy, Radical | 1 | 1993 | 19 | 0.030 |
Why?
|
| Mastectomy, Simple | 1 | 1993 | 23 | 0.030 |
Why?
|
| Male | 8 | 2023 | 359718 | 0.030 |
Why?
|
| Neoplasm Staging | 6 | 1998 | 11152 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 1998 | 2943 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 1995 | 391 | 0.030 |
Why?
|
| Survival Rate | 4 | 2000 | 12810 | 0.030 |
Why?
|
| Middle Aged | 13 | 2005 | 220359 | 0.020 |
Why?
|
| Prognosis | 5 | 2005 | 29661 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 1995 | 1832 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1995 | 1791 | 0.020 |
Why?
|
| Vincristine | 1 | 1991 | 1038 | 0.020 |
Why?
|
| Prednisone | 1 | 1991 | 1566 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1991 | 1631 | 0.020 |
Why?
|
| Aged | 9 | 2005 | 169143 | 0.020 |
Why?
|
| Breast | 1 | 1994 | 1963 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 1991 | 2222 | 0.020 |
Why?
|
| Female | 15 | 2005 | 391246 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 1998 | 313 | 0.020 |
Why?
|
| Retrospective Studies | 8 | 2000 | 80345 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1991 | 2208 | 0.010 |
Why?
|
| Methotrexate | 1 | 1991 | 1718 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2001 | 8055 | 0.010 |
Why?
|
| Follow-Up Studies | 5 | 2005 | 39262 | 0.010 |
Why?
|
| Survival Analysis | 2 | 1994 | 10185 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2001 | 64981 | 0.010 |
Why?
|
| Adult | 10 | 2005 | 220007 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1998 | 646 | 0.010 |
Why?
|
| Actuarial Analysis | 2 | 1994 | 374 | 0.010 |
Why?
|
| Tattooing | 1 | 2003 | 57 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2005 | 58980 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 1997 | 3530 | 0.010 |
Why?
|
| Mathematics | 1 | 2003 | 707 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2003 | 488 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2005 | 6831 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2003 | 20509 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2001 | 881 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2003 | 946 | 0.010 |
Why?
|
| Posture | 1 | 2003 | 953 | 0.010 |
Why?
|
| Diarrhea | 1 | 2005 | 1319 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5799 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2005 | 1131 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4899 | 0.010 |
Why?
|
| Antidotes | 1 | 1997 | 138 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 12531 | 0.010 |
Why?
|
| Recurrence | 1 | 1998 | 8483 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1998 | 4902 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1997 | 363 | 0.010 |
Why?
|
| Leucovorin | 1 | 1997 | 641 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3520 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2003 | 2512 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2005 | 2821 | 0.010 |
Why?
|
| Thorax | 1 | 1997 | 553 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10826 | 0.010 |
Why?
|
| Risk Factors | 1 | 2000 | 74333 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2000 | 936 | 0.010 |
Why?
|
| Time Factors | 3 | 2005 | 40139 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1992 | 228 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 1643 | 0.010 |
Why?
|
| Electrons | 1 | 1992 | 264 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 5066 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 4393 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1994 | 6238 | 0.000 |
Why?
|
| Antineoplastic Agents | 2 | 2000 | 13627 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13312 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20080 | 0.000 |
Why?
|
| Lung | 1 | 2003 | 9994 | 0.000 |
Why?
|
| Brachytherapy | 1 | 1992 | 1238 | 0.000 |
Why?
|
| Quality of Life | 1 | 2005 | 13308 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1994 | 12159 | 0.000 |
Why?
|
| Disease Progression | 1 | 1997 | 13505 | 0.000 |
Why?
|
| Age Factors | 1 | 1994 | 18413 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1992 | 41337 | 0.000 |
Why?
|